Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Freeman Chris, Directeur Commercial. Insider active across 1 company, notably Guardant Health, Inc.. Aggregated, 28 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €42k. History available since 15 June 2022. The latest transaction was disclosed on 1 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Chris Freeman is the Chief Commercial Officer at Guardant Health, Inc. He is responsible for the company's commercial strategy and growth. His role is essential in developing customer relationships and supporting sales initiatives. With his expertise, he contributes to implementing strategies that promote Guardant Health's growth.